Analyst firms, including Citigroup and William Blair, have issued ratings and price targets for Dexcom.

The entities involved

• Dexcom →

  company that develops, manufactures and distributes continuous glucose monitoring systems

  • Tandem Mobi utilizes Dexcom G7 technology for monitoring.Mon 09:18
  • Oura announces partnerships with Dexcom and Resmed for health feature integration, while noting that regulatory uncertainty affects its product scope.Wed 08:52
• Citigroup →

  American investment bank and financial services corporation

  • Citigroup provided analyst ratings and targets for Autodesk stock, which trades on Nasdaq.Mon 11:05
  • Citigroup and Jefferies Financial Group downgraded the stock rating for Yara International on June 26, 2026.Mon 10:14
• MarketBeat →

  American personal finance blog

  • Apple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Mon 17:22
  • MarketBeat aggregates data on IDT Corporation stock performance.Mon 17:15

Related events

• Dexcom stock received a raised price objective and rating restatement from analysts, accompanied by SEC filings.Sep 11
• MarketBeat published consensus price targets and analyst ratings for Graco and Manitowoc on September 13, 2026.Sep 13
• Citigroup reiterated an outperform rating on PubMatic, while Scotiabank raised its shares rating and target price, and Jefferies raised its price target.Sep 6
• Truist Financial and Citigroup provided buy ratings and price objectives for Crown stock.Aug 19
• A company is receiving analyst price targets and ratings, concurrent with institutional investors filing required Form 13F reports with the SEC.Aug 26